Early Diuretic Strategies and the Association With In Hospital and Post Discharge Outcomes in Acute Heart Failure.
BACKGROUND Decongestion is a primary goal during hospitalizations for decompensated heart failure (HF) However, data surrounding the preferred route and strategy of diuretic administration are limited with varying results in prior studies. METHODS This is a retrospective analysis using patients from ASCEND HF with a stable diuretic strategy in the first 24 hours following randomization. Patients were divided into three groups: intravenous (IV) continuous, IV bolus and oral strategy. Baseline characteristics, in hospital outcomes, 30 day composite cardiovascular mortality or HF rehospitalization and 180 day all cause mortality were compared across groups. Inverse propensity weighted modeling was used for adjustment. RESULTS Among 5,738 patients with a stable diuretic regimen in the first 24 hours (80% of overall ASCEND trial) 3,944 (68.7% patients received IV intermittent bolus administration of diuretics, 799 (13.9% patients received IV continuous therapy and 995 (17.3% patients with oral administration. Patients in the IV continuous group had a higher baseline creatinine (IV continuous 1.4 [1.1 1.7] intermittent bolus 1.2 [1.0 1.6] oral 1.2 [1.0 1.4] mg/dL; p<0.001) and high NTproBNP (IV continuous 5,216 [2,599 11,603] intermittent bolus 4,944 [2,339 9,970] oral 3,344 [1,570 7,077] pg/mL; p<0.001) There was no difference between IV continuous and intermittent bolus group in weight change, total urine output and change in renal function till 10 days/discharge (adjusted p>0.05 for all) There was no difference in 30 day mortality and HF readmission (adjusted OR 1.08 [95%CI: 0.74, 1.57] p=0.701) and 180 days mortality (adjusted OR 1.04 [95%CI: 0.75, 1.43] p=0.832) CONCLUSION In a large cohort of patients with decompensated HF, there were no significant differences in diuretic related in hospital, or post discharge outcomes between IV continuous and intermittent bolus administration. Tailoring appropriate diuretic strategy to different states of acute HF and congestion phenotypes needs to be further investigated.
American heart journal